Untitled

Initiatives Webinar series from Saxe Communications with support from Medtronic* present…”The Case for Minimally-Invasive Hepatic Microwave Ablation”

Microwave ablation (MWA) of hepatic malignancies is an effective treatment strategy for patients unable to tolerate definitive resection or transplantation.  The laparoscopic approach is an underutilized technique and prognostic factors of survival in this setting are not well characterized.  The aim of this webinar will be to present optimal approaches and techniques to consider regarding patient selection, tumor location and other prognostic factors for MWA.

Learning Objectives  |  At the end of this session, participants should be able to:

1. Describe hepatic microwave ablation in the surgical setting through review of evidence-based medicine, and expert practice
2. Discuss the minimal standard of ultrasound equipment needed to perform non-resectable tumor ablation
3. Recognize the optimal quality standard for non-resectable liver tumor ablation

Presenter: Robert C.G. Martin, II, M.D., Ph.D., FACS  | Director, Division of Surgical Oncology  |  Director, Upper GI & HPB Multi-Disciplinary Clinic  |  Academic Advisory Dean  |  University of Louisville

Target Audience:  Physicians & Nurses

Continuing Education for Physicians and Nurses: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and Saxe Healthcare Communications. Your CE Source is accredited by ACCME for 1 AMA PRA Category 1 Credit.
This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

Support for this educational activity from Medtronic*

Questions should be addressed to webinar@saxecommunications.com

* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.